Roumen V. Milev, MD, PhD

  • 4Articles
  • 42.2KReads
  • 2016–2023Active
  • 50Collaborators
  • 150Citations

About

Roumen V. Milev, MD, PhD, is affiliated with the Departments of Psychiatry and Psychology at Queen’s University in Kingston, Canada. Milev has published extensively on major depressive disorder (MDD), focusing on topics such as antidepressant treatment response prediction using machine learning, the cognitive effects of ketamine in unipolar and bipolar depression, and functional recovery during early optimized treatment. His work includes analyses of symptomatic and functional outcomes related to escitalopram and adjunctive aripiprazole therapies. Milev’s research has appeared in Psychiatrist.com from 2016 to 2023.

Publications

JCP
Machine Learning Prediction of Quality of Life Improvement During Antidepressant Treatment of Patients With Major Depressive Disorder: A STAR*D and CAN-BIND-1 Report
Original Research

Machine Learning Prediction of Quality of Life Improvement During Antidepressant Treatment of Patients With Major Depressive Disorder: A STAR*D and CAN-BIND-1 Report

November 15, 2023

Quality of life is an important patient-centric outcome. Using machine learning methods, this study found that quality of life improvement with antidepressant treatment can be predicted using early depression...
, , , et al
JCP
Systematic Review

Cognitive Effects of Ketamine in Depression

January 4, 2022

The cognitive effects of ketamine have not been thoroughly investigated in depressed populations. This systematic review sought to determine the objective neurocognitive effects of ketamine in individuals with unipolar...
, , , et al
JCP
Original Research

CAN-BIND-1 Outcomes and Early Response Prediction in MDD

February 5, 2019

Antidepressant medications are often prescribed with little certainty about their potential effectiveness in individual patients. Can early symptom reduction help predict later symptomatic and functional outcomes of antidepressant treatment?...
, , , et al
PCC
Article

Early Optimized Treatment in MDD

September 1, 2016

Delayed depression treatment is associated with poorer clinical outcomes. This review highlights the evidence for a more rapid, individualized treatment approach to improve outcomes for individual patients.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe